Showing results (231-240 of 466) with videos related to
Sort By:
Pageof 47
International Journal of Radiation Oncology, Biology, Physics|September 1, 1986
Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione contentT L Phillips, J B Mitchell, W de Graff, et al.Free Radical Research Communications|January 1, 1990
Superoxide reaction with nitroxidesA Samuni, C M Krishna, J B Mitchell, et al.International Journal of Radiation Oncology, Biology, Physics|March 15, 1997
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/mlA V D'Amico, R Whittington, I Kaplan, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 1989
Use of monochlorobimane for glutathione measurements in hamster and human tumor cell linesJ A Cook, H I Pass, A Russo, et al.European Journal of Pharmacology|November 28, 1989
Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptorsP Boksa, M Quik, J B Mitchell, et al.International Journal of Radiation Biology|November 1, 1989
Radiobiology and clinical application of halogenated pyrimidine radiosensitizersJ B Mitchell, A Russo, J A Cook, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508C N Coleman, R C Urtasun, T H Wasserman, et al.International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumorsL N Shulman, L Buswell, N Riese, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximineK Malaker, S J Hurwitz, E A Bump, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 1992
Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxideM C Krishna, D A Grahame, A Samuni, et al.Pageof 47